On December 2, Congress introduced the CBD Product Safety and Standardization Act (the Act), a bipartisan bill that would establish federal standards for food and beverage products containing hemp-derived cannabidiol (CBD). If enacted, the Act would:
Require the Food and Drug Administration (FDA) to regulate CBD similarly to any other food ingredient; Allow FDA to regulate CBD as a food additive; Subject these products to enforceable safeguards to ensure safety and accountability; and Task the FDA with establishing CBD content limits, packaging and labeling requirements, and determining in which categories of food CBD is appropriate for use.
In a press release, U.S. Representative Kathleen Rice (NY-04), one of the sponsors of the Act, commented that:
“CBD products are exploding in popularity, but the lack of federal regulation surrounding them has put consumers at risk and left businesses looking for clarity. The bipartisan CBD Product Safety and Standardization Act will establish the clear regulatory framework needed to provide stability for business and ensure unsafe products stay off the shelves.”
In other words, the goal of this new legislation is to protect consumers, provide CBD companies with much needed regulatory clarity, eliminate bad actors and dangerous CBD products in the